163 related articles for article (PubMed ID: 28575142)
1. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
Mason EF; Pozdnyakova O; Li B; Dudley G; Dorfman DM
Am J Clin Pathol; 2017 Jul; 148(1):33-41. PubMed ID: 28575142
[TBL] [Abstract][Full Text] [Related]
2. CD200 expression in B-cell chronic lymphoproliferative disorders.
El Desoukey NA; Afify RA; Amin DG; Mohammed RF
J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
[TBL] [Abstract][Full Text] [Related]
3. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
Al-Zubaidi HK; Hughes SF
Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
[No Abstract] [Full Text] [Related]
4. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
5. CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders.
Pillai V; Pozdnyakova O; Charest K; Li B; Shahsafaei A; Dorfman DM
Am J Clin Pathol; 2013 Oct; 140(4):536-43. PubMed ID: 24045551
[TBL] [Abstract][Full Text] [Related]
6. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
7. CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.
Schmieg JJ; Muir JM; Aguilera NS; Auerbach A
Curr Oncol; 2021 Dec; 28(6):5124-5147. PubMed ID: 34940069
[TBL] [Abstract][Full Text] [Related]
8. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
[TBL] [Abstract][Full Text] [Related]
9. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.
Venkataraman G; Aguhar C; Kreitman RJ; Yuan CM; Stetler-Stevenson M
Am J Clin Pathol; 2011 Oct; 136(4):625-30. PubMed ID: 21917686
[TBL] [Abstract][Full Text] [Related]
10. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders.
Kotsianidis I; Nakou E; Spanoudakis E; Bouchliou I; Moustakidis E; Miltiades P; Vadikolia CM; Szydlo R; Karadimitris A; Tsatalas C
Am J Clin Pathol; 2011 Sep; 136(3):400-8. PubMed ID: 21846915
[TBL] [Abstract][Full Text] [Related]
12. Flow Cytometry of CD5-Positive Hairy Cell Leukemia.
Cenariu D; Rus I; Bergthorsson JT; Grewal R; Cenariu M; Greiff V; Tigu AB; Dima D; Selicean C; Petrushev B; Zdrenghea M; Fromm J; Aanei CM; Tomuleasa C
Mol Diagn Ther; 2023 Sep; 27(5):593-599. PubMed ID: 37291380
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Diagnostic Usefulness of CD200 Expression in B-cell Chronic Lymphoproliferative Disorders.
Purohit A; Satiza M; Somasundaram V; Sharma R; Mishra P; Seth T; Tyagi S; Mahapatra M; Pati HP; Saxena R
Indian J Hematol Blood Transfus; 2023 Oct; 39(4):684-690. PubMed ID: 37786819
[TBL] [Abstract][Full Text] [Related]
15. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of hairy cell leukemia by flow cytometry.
Stetler-Stevenson M; Tembhare PR
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():11-3. PubMed ID: 21504292
[TBL] [Abstract][Full Text] [Related]
17. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
Li W; Fang P; Fu G; Liang H; Peng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
[TBL] [Abstract][Full Text] [Related]
18. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics.
Dong HY; Weisberger J; Liu Z; Tugulea S
Am J Clin Pathol; 2009 Apr; 131(4):586-95. PubMed ID: 19289595
[TBL] [Abstract][Full Text] [Related]
20. Consistency of the Moreau CLL score.
Sorigue M; Sarrate E; Franch-Sarto M; Feliu E; Junca J
J Clin Lab Anal; 2018 Jun; 32(5):e22376. PubMed ID: 29282771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
